Keywords: dong, wha, licenses, osteoporosis, drug, candidates, seoul

Dong Wha licenses osteoporosis drug candidates to P&G

Article | 09 July 2007

Print This

Seoul, Korea-based Dong Wha and USA-based Procter & Gamble have entered a strategic alliance under which P&G will have rights ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in